Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins alone versus statins + aspirin versus statins + pentoxifylline for atherosclerotic lesion in chronic kidney disease
2009-016595-77Phase 4Active
- Sponsor
- Juan Francisco Navarro González
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin and pentoxifylline in atherosclerotic disease and chronic kidney disease (CKD) (3 arms), sponsored by Juan Francisco Navarro González. Primary endpoint: Carotid intima-media thickness. Started Dec 2009; status: active.
02
Drugs
aspirinpentoxifylline
03
Conditions
atherosclerotic diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on 2009-016595-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016595-77.